Literature DB >> 10694643

Clinical importance of late recurrence in soft-tissue sarcomas.

J F Gibbs1, R J Lee, D L Driscoll, B E McGrath, E R Mindell, W G Kraybill.   

Abstract

BACKGROUND AND OBJECTIVES: Soft-tissue sarcomas (STS) represent a diverse histologic group of malignancies at risk for local and distant failure. We studied the impact of late (5 or more years) vs. early recurrence (less than 5 years) on subsequent outcome.
METHODS: Four hundred sixty-eight patients with STS treated between 1962 and 1992 were evaluated for late (n = 39; 8%) or early (n = 253; 54%) recurrence. Clinical and pathologic factors were reviewed. Survival data were analyzed by the Kaplan-Meier method and the log-rank test.
RESULTS: Of the 39 patients with a late recurrence (median follow-up 156 months), 18 patients had local recurrence, 7 patients developed distant recurrence, and 14 patients had local and distant recurrence. Thirty patients with late local and/or distant recurrence underwent complete or wide excision (n = 16), amputation (n = 4), or local resection (n = 10). The overall 5-year survival rate following late recurrence was 61%. The 5-year overall survival rate was statistically better for patients with a late local recurrence alone than for patients with distant failure, 94% vs. 36%, respectively (P = 0.003). Neither the site of the primary STS, age, primary margin status, nor histology had any effect on subsequent local or distant failure and subsequent survival.
CONCLUSIONS: These data suggest that an aggressive approach is appropriate in patients who present with late recurrence (more than 5 years) following treatment of the primary STS. Impressive survival rates can be achieved in the treatment of local recurrences. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2000        PMID: 10694643     DOI: 10.1002/(sici)1096-9098(200002)73:2<81::aid-jso5>3.0.co;2-9

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  6 in total

Review 1.  [Soft tissue sarcoma: how can posttreatment alterations be distinguished from recurrences?]

Authors:  I-M Noebauer-Huhmann; T Grieser
Journal:  Radiologe       Date:  2017-11       Impact factor: 0.635

2.  What Is the Success of Repeat Surgical Treatment of a Local Recurrence After Initial Wide Resection of Soft Tissue Sarcomas?

Authors:  Hideshi Sugiura; Satoshi Tsukushi; Masahiro Yoshida; Yoshihiro Nishida
Journal:  Clin Orthop Relat Res       Date:  2018-09       Impact factor: 4.176

3.  Local recurrence after initial multidisciplinary management of soft tissue sarcoma: is there a way out?

Authors:  Sarantis Abatzoglou; Robert E Turcotte; Abdurahman Adoubali; Marc H Isler; David Roberge
Journal:  Clin Orthop Relat Res       Date:  2010-11       Impact factor: 4.176

Review 4.  Follow-up Strategies for Primary Extremity Soft-tissue Sarcoma in Adults: A Systematic Review of the Published Literature.

Authors:  Dietmar Dammerer; Annelies VAN Beeck; Viktoria Schneeweiss; Anton Schwabegger
Journal:  In Vivo       Date:  2020 Nov-Dec       Impact factor: 2.155

5.  The treatment and outcome of patients with soft tissue sarcomas and synchronous metastases.

Authors:  John M Kane; J William Finley; Deborah Driscoll; William G Kraybill; John F Gibbs
Journal:  Sarcoma       Date:  2002

6.  The role of irradiation in the management of locally recurrent non-metastatic soft tissue sarcoma of extremity/trunkal locations.

Authors:  James Fontanesi; Michael P Mott; David R Lucas; Peter R Miller; Michael J Kraut
Journal:  Sarcoma       Date:  2004
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.